← FDA DRUG APPROVALS

FDA ANDA · ANDA077344

DONEPEZIL HYDROCHLORIDE

Sponsor: HERITAGE PHARMA

APPLICATION
ANDA077344
TYPE
ANDA
ORIGINAL APPROVAL
2011-05-31
LATEST ACTION
2025-03-13
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

DONEPEZIL HYDROCHLORIDEDiscontinued
DONEPEZIL HYDROCHLORIDE 10MG · TABLET · ORAL
DONEPEZIL HYDROCHLORIDEDiscontinued
DONEPEZIL HYDROCHLORIDE 5MG · TABLET · ORAL

Approval history

2025-03-13Labeling · Supplement 2 · standardAP
2011-05-31OriginalAP
2010-06-29Labeling · Supplement 1AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →